Approach to a patient with pruritus in 10marks format for 3rd yr dermatology post graduate theory examination

Reading File
Finding Sources
Searching the Web

approach to patient with pruritus dermatology postgraduate examination

Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have all the material I need. Let me compile the comprehensive 10-mark PG examination answer.

Approach to a Patient with Pruritus

(10 Marks — 3rd Year Dermatology Postgraduate Theory Examination)

DEFINITION

Pruritus (itch) is an unpleasant cutaneous sensation that provokes the desire to scratch. It is the most common skin-related symptom. When it persists for ≥6 weeks, it is termed chronic pruritus, which has a lifetime prevalence of ~22% in the general population.

CLASSIFICATION (IFSI 2007)

The International Forum for the Study of Itch (IFSI) classifies chronic pruritus into three clinical groups based on skin findings:
GroupClinical Features
Group IPruritus on inflamed (lesional) skin — primary dermatoses
Group IIPruritus on non-inflamed (non-lesional) skin — systemic/neuropathic/psychogenic
Group IIIPruritus with secondary scratch-induced lesions — prurigo nodularis, lichen simplex chronicus
Etiologic categories: Dermatologic · Systemic · Neurologic · Psychogenic · Mixed · Unknown

HISTORY

A precise, structured history is essential:

1. Characteristics of Itch

  • Onset — acute (days–weeks) vs. chronic (≥6 weeks)
  • Duration and course — continuous, episodic, progressive
  • Location — localized (scalp, anogenital, forearm) vs. generalized
  • Severity — Numerical Rating Scale (NRS 0–10) or Visual Analogue Scale (VAS)
  • Quality — burning, stinging, tickling (neuropathic); crawling sensation (parasitophobia)
  • Time pattern — nocturnal (scabies, AD); aquagenic (polycythemia vera, mastocytosis); postbath

2. Aggravating/Relieving Factors

  • Heat, sweating, friction, woolen clothing (AD)
  • Water contact (aquagenic pruritus)
  • Relief with ice packs (brachioradial pruritus — a neuropathic clue)
  • Sunlight exposure (photodermatoses)

3. Associated Symptoms

  • Skin rash (nature and distribution)
  • Jaundice, dark urine, pale stools → cholestatic disease
  • Weight loss, night sweats, lymphadenopathy → lymphoma/malignancy
  • Polydipsia, polyuria → diabetes mellitus
  • Fatigue, cold intolerance, hair loss → thyroid disease
  • Burning/tingling with normal skin → neuropathic

4. Drug History

  • Opioids (μ-receptor-mediated itch), ACE inhibitors, hydroxyurea, chloroquine, statins, calcium channel blockers — any recent medication change?

5. Personal & Family History

  • Atopy (AD, asthma, allergic rhinitis)
  • Chronic kidney disease, liver disease, HIV

6. Social History

  • Contacts with similar itch (scabies)
  • Travel history (parasitic infestations)
  • Occupation (fiberglass dermatitis)
  • Pregnancy (intrahepatic cholestasis of pregnancy, pruritic urticarial papules and plaques of pregnancy [PUPPP])

7. Quality of Life

  • Sleep disturbance, anxiety, depression (ItchyQol questionnaire)

EXAMINATION

A. Dermatological Examination

Examine skin, scalp, hair, nails, mucous membranes completely in good lighting.
Step 1 — Identify primary lesions:
Primary lesionLikely diagnosis
Urticarial whealsUrticaria
Vesicles/bullaeDermatitis herpetiformis, pemphigoid
Eczematous plaques, lichenification (flexural)Atopic dermatitis
Silvery plaques on extensor surfacesPsoriasis
Violaceous polygonal papulesLichen planus (95% pruritic)
Burrows (web spaces, wrists, genitalia)Scabies
Erythroderma + Sézary cellsCTCL/Sézary syndrome
Pigmented macules/urticaria factitiaMastocytosis
Step 2 — Secondary scratch lesions (when no primary disease identified):
  • Excoriations, prurigo papules/nodules, lichenification, hyperpigmented scars, linear streaks
  • Their distribution is a clue (e.g., sparing the mid-back "butterfly sign" = notalgia paresthetica; linear dorsolateral forearm = brachioradial pruritus)
Step 3 — Signs of systemic disease:
  • Jaundice, hepatosplenomegaly, ascites → hepatic/cholestatic
  • Pallor, excoriations without primary lesions + uraemic frost → CKD
  • Lymphadenopathy + night sweats → lymphoma
  • Thyroid enlargement, exophthalmos, pretibial myxedema → thyroid
  • Dermographism → urticaria/mastocytosis
  • "Butterfly sign" (mid-back spared in CKD pruritus — patient cannot reach)

INVESTIGATIONS

Initial Baseline Work-up (for generalized pruritus without primary skin lesion):

InvestigationWhat it detects
CBC with differentialEosinophilia (parasites), polycythemia vera, leukemia, lymphoma
LFTs + bilirubinCholestatic/hepatic pruritus (PBC, hepatitis C)
Renal function (BUN, creatinine, eGFR)CKD-associated pruritus
Fasting blood glucose / HbA1cDiabetic neuropathy
TFTs (TSH, T4)Hyperthyroidism/hypothyroidism
Serum iron, ferritinIron-deficiency (polycythemia vera workup)
HIV serologyHIV-associated itch
Chest X-rayLymphoma, sarcoidosis

Second-line Work-up (if initial is normal or guided by suspicion):

InvestigationIndication
Serum IgE, skin prick testsAtopy
ANA, ANCAConnective tissue diseases
Serum protein electrophoresisMyeloma, amyloidosis
JAK2 V617F mutation / BM biopsyPolycythemia vera
Stool microscopy, serologyParasitic infestation
Skin biopsy (lesional + peri-lesional)CTCL, dermatitis herpetiformis, pemphigoid, mastocytosis
CT chest/abdomen/pelvisOccult lymphoma/solid malignancy
Cervical/lumbar MRINeuropathic pruritus (brachioradial pruritus, notalgia paresthetica)
ICP (bile acids) in pregnancyIntrahepatic cholestasis of pregnancy
Key principle: Chronic progressive generalized pruritus without primary skin lesions should always prompt systemic workup, even though no single clinical feature reliably predicts a systemic etiology.

TREATMENT

I. General / Non-pharmacological Measures

  • Identify and treat underlying cause
  • Lukewarm baths, avoid hot water (vasodilatory)
  • Fragrance-free emollients liberally (restore barrier)
  • Cotton clothing; avoid wool/synthetic
  • Nail trimming (prevent excoriation)
  • Cool environmental temperature, fan
  • Avoidance of triggers (irritants, allergens)

II. Topical Therapy

DrugMechanism / Use
CorticosteroidsReduce skin inflammation (inflamed pruritus); not for non-lesional pruritus
Calcineurin inhibitors (tacrolimus, pimecrolimus)AD, lichen planus — especially face/flexures
Capsaicin (0.025–0.1%)TRPV1 desensitization; CKD pruritus, notalgia paresthetica
Topical anaesthetics (lidocaine, EMLA)Localized pruritus
Doxepin cream (5%)H1+H2 blockade; short-term use; risk of sensitization
Menthol (1–3%)Cooling via TRPM8; symptomatic relief
CrotamitonScabies + antipruritic

III. Systemic Therapy

DrugIndication / Mechanism
Antihistamines (H1) — cetirizine, hydroxyzineHistamine-mediated itch (urticaria, allergic dermatoses); sedating agents (hydroxyzine) useful for nocturnal pruritus
Gabapentin / PregabalinNeuropathic pruritus, CKD pruritus, brachioradial pruritus
Mirtazapine (7.5–15 mg nightly)CTCL pruritus, nocturnal pruritus (H1 + 5-HT3 antagonism)
Doxepin (10–75 mg)H1+H2 + TCA; nocturnal pruritus
μ-opioid antagonists (naltrexone, naloxone)Cholestatic, CKD, CTCL pruritus (central opioid modulation)
κ-opioid agonists (nalfurafine, difelikefalin)CKD pruritus
CholestyramineCholestatic pruritus
RifampicinCholestatic pruritus (CYP induction)
UDCAPrimary biliary cholangitis
SSRIs (sertraline, fluvoxamine)Cholestatic, paraneoplastic pruritus
NK1 antagonists (aprepitant)CTCL, drug-induced pruritus
Dupilumab (anti-IL-4Rα)AD-associated pruritus
Nemolizumab (anti-IL-31Rα)AD and prurigo nodularis
Immunosuppressants (ciclosporin, methotrexate)Severe AD, psoriasis

IV. Phototherapy

  • NB-UVB — CKD pruritus (80–90% response), HIV-associated pruritus, CTCL, prurigo nodularis
  • PUVA — aquagenic pruritus, polycythemia vera, CTCL
  • UVA-1 — AD, mastocytosis
In CKD pruritus, phototherapy acts systemically — unilateral exposure relieves pruritus bilaterally.

V. Psychological Approaches

  • Group psychotherapy, CBT (habit-reversal training)
  • Biofeedback, acupuncture
  • Treat comorbid anxiety and depression

PREVALENCE SNAPSHOT (Selected Conditions)

ConditionPruritus Prevalence
Atopic dermatitis100% (diagnostic criterion)
Lichen planus~95%
Psoriasis60–95%
Primary biliary cholangitis~80%
Sézary syndrome (CTCL)>90%
End-stage CKD on hemodialysis25–45%
Polycythemia vera30–50%
Hodgkin lymphoma≤30%

SUMMARY FLOW

Pruritus
    │
    ├─ Primary skin lesion present?
    │       YES → Treat underlying dermatosis
    │       NO ↓
    │
    ├─ Thorough history + examination
    │
    ├─ Baseline investigations (CBC, LFT, KFT, TFT, RBS, HIV)
    │
    ├─ Systemic cause found? → Treat cause + symptomatic antipruritic
    │
    ├─ Neuropathic features? → Neuroimaging + gabapentin/pregabalin
    │
    ├─ Psychological cause? → CBT + SSRIs
    │
    └─ Unknown (15%) → Empirical therapy + longitudinal follow-up

Sources: Dermatology 2-Volume Set 5e (Ständer et al., Ch. 6: Pruritus and Dysesthesia); Fitzpatrick's Dermatology 9e, Ch. on Atopic Dermatitis & Phototherapy.

Classify Adverse Drug Reaction.Management of TEN in 10marks formation for 3rd yr dermatology post graduate theory examination

Finding Sources
Finding Sources
Searching the Web

adverse drug reaction classification TEN toxic epidermal necrolysis management dermatology

Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.